nCage Therapeutics
Biotechnology Research • • 1-10 Employees
Company overview
| Headquarters | XX |
| Website | |
| NAICS | 541714 |
| Employees | 1-10 |
Key Contact at nCage Therapeutics
John Bason
Chief Executive Officer
nCage Therapeutics Email Formats
nCage Therapeutics uses 1 email format. The most common is {first name}{last name} (e.g., johndoe@ncage.org), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}{last name} | johndoe@ncage.org | 100% |
About nCage Therapeutics
nCage Therapeutics is developing a novel synthetic protein cage based on the bacterial TRAP protein. Protein cages are synthetic virus-like particles (VLPs), that can be used to display biological material on their surface, or transport molecules such as nucleic acids or proteins into the interior of the cell. Our cages are programmable and have significant potential as both drug delivery systems and vaccines.
nCage Therapeutics revenue & valuation
| Annual revenue | $598,885 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $2,000,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
nCage Therapeutics has 2 employees across 2 departments.
Departments
Number of employees
Funding Data
nCage Therapeutics has never raised funding before.
nCage Therapeutics Tech Stack
Discover the technologies and tools that power nCage Therapeutics's digital infrastructure, from frameworks to analytics platforms.
CDN
Form builders
JavaScript libraries
Miscellaneous
Security
Widgets
Miscellaneous
Hosting
Page builders
JavaScript libraries
Maps
United States
Canada
United Arab Emirates
Australia
United KingdomFrequently asked questions
4.8
40,000 users
